Chemical Characterization and Effect of a Lactobacilli-Postbiotic on Streptococcus mutans Biofilm In Vitro.

Postbiotic is the term used to define the soluble factors, metabolic products, or byproducts released by live probiotic bacteria or after its lysis. The objective of this study was to carry out the chemical characterization of the postbiotic of Lacticaseibacillus rhamnosus LR-32 and to evaluate its in vitro effect on the development of the Streptococcus mutans biofilm. After the cultivation of the probiotic strain, the postbiotic was extracted by centrifuging the culture and filtering the supernatant. This postbiotic was characterized by using gas chromatography coupled with mass spectrometry (GC-MS), and then it was used to determine the growth inhibition of S. mutans in its planktonic form; additionally, its effects on the following parameters in 48 h biofilm were evaluated: viable bacteria, dry weight, and gene expression of glucosyltransferases and VicR gene. The control group consisted of the biofilm without any treatment. A paired t-test was performed for statistical analysis, with the p-value set at 5%. Seventeen compounds of various chemical classes were identified in the postbiotic, including sugars, amino acids, vitamins, and acids. The treatment with the postbiotic led to an inhibition of the growth of S. mutans in its planktonic form, as well as a decrease in the number of viable bacteria, reduction in dry weight, and a negative regulation of the gene expression of gtfB, gtfC, gtfD, and vicR in its biofilm state, compared with the nontreated group (p < 0.05). The postbiotic of L. rhamnosus impaired the development of S. mutans biofilm.

Salivary fluoride bioavailability after use of high-fluoride dentifrices with different compositions: A short-term randomized clinical trial.

OBJECTIVE: The objective of the study was to evaluate the kinetics of salivary F bioavailability after the use of high-fluoride dentifrices with different compositions and their amount of total soluble fluoride (TSF). METHODS: A short-term clinical randomized trial was performed in which 15 adult participants were randomly allocated into three groups: 5000 ppm F-dentifrice, 5000 ppm F-dentifrice + TCP (tri-calcium phosphate) and 1450 ppm F-dentifrice. Unstimulated saliva was collected at different times: baseline (before toothbrushing), immediately after brushing/water rinsing and at 5, 15 and 30 min and 1, 2, 4, 8 and 12 h after brushing. The TSF in dentifrices and saliva samples was analysed using an ion-specific electrode. For statistical analysis, the paired t-test and Kruskal-Wallis were used with Dunn's post-test with a 95% confidence interval. RESULTS: There was no significant difference between the declared TSF and that found in 5000 ppm F-dentifrice and 1450 ppm F-dentifrice (p ≥ 0.13); however, in the 5000 ppm F-dentifrice + TCP, approximately 500 ppm less TSF was observed (p = 0.0024). The area under the curve (AUC, µg F/ml min-1 ) of both high-fluoride dentifrices (321.7 ± 84.0 and 223.6 ± 55.1 for the one without and with TCP, respectively) was higher than the conventional one (89.97 ± 15.6) attesting a higher F-bioavailability (p = 0.04). Furthermore, they were able to provide F-salivary levels higher than the baseline for up to 2 h, while this time was 1 h for the 1450 ppm F-dentifrice (p ≤ 0.003). CONCLUSION: Both high-fluoride dentifrices similarly increased the salivary-F bioavailability in comparison with 1450 ppm F-dentifrice, despite the lower TSF presented by the dentifrice containing TCP.

Nocturnal Salivary Fluoride Bioavailability After Brushing with a High-fluoride Dentifrice.

The use of fluoridated dentifrices is recognized as the main reason for the decline of dental caries and its effect is associated with the bioavailability of fluoride (F) in the oral cavity. High-fluoride dentifrice has been indicated for patients at high risk of caries and management of root lesions. This study aimed to evaluate the bioavailability of F in saliva after the use of high-fluoride dentifrice during the nocturnal period. Fifteen healthy adults participated in this is in vivo and crossover study in which the concentration of F in their saliva was determined after brushing with the tested dentifrices: a conventional (1450 ppm F) or with high-fluoride concentration (5000 ppm F). Before brushing, the participants collected the non-stimulated saliva (baseline), immediately after brushing (time zero) and after 5min, 2h, 4h, and 8h, during the nocturnal period (between 10:00 pm and 06:00 am). The salivary F concentration was determined using a specific F ion electrode. Regarding statistical analysis, a paired t-test was used to compare dentifrices with p fixed at 5%. At baseline, there was no significant difference between groups (p>0.001). Immediately after brushing, both dentifrices increased the F salivary concentration, with the highest concentration reached in time zero; however, the use of 5000 ppm F dentifrice maintained the higher F salivary concentration at all times evaluated (p<0.001), remaining higher until 8 h after brushing. Furthermore, this treatment showed higher F bioavailability in relation to time, evaluated by the area under the curve (p<0.001). Thus, it can be concluded that the high-fluoride dentifrice increased the bioavailability of salivary F during the nocturnal period in comparison with conventional dentifrice.

Association of chlorhexidine and high fluoride dentifrice on Streptococcus mutans viability using an in vitro biofilm model / Associação de clorexidina e dentifricio com alta concentração de flúor na viabilidade de Streptococcus mutans em um modelo de biofilmes in vitro

Objective: this in vitro study investigated the effect of high-fluoride dentifrice, Chlorhexidine (CHX), and their association on the viability of Streptococcus mutans using a biofilm model. Material and Method: biofilms were anaerobically grown on glass slides that were vertically suspended in 24-well plates for 5 days. After 48 h of initial growth, biofilms were treated for the next 72 h, 2x/day with 0.12% CHX and 2%, F as 0.08% and 0.4% NaF and their association. Results: CHX treatment decreased the bacteria counts either alone or in association with both F concentrations, when compared with control group and the F treatments alone (p < 0.05). Conclusion: no additional effect was observed when CHX and F were used in combination, when compared with CHX used alone.

Objetivo: este estudo avaliou, o efeito do dentifrício com alta concentração de fluor (F), da clorexidina (CHX) e da associação destes na viabilidade de Streptococcus Mutans (SM) utilizando um modelo de biofilme in vitro. Materiais e Métodos: biofilme cresceram anaerobicamente em lamínulas de vidro suspensas, verticalmente, em placas de 24 poços por 5 dias. Após 48h do crescimento inicial, o biofilme formado foi submetido a um tratamento por 72h, 2x/ dia com CHX 0.12%, F na forma de NaF a 0.08% e 0.4%, suas associações, CHX 2% (controle positivo) e solução salina (controle negativo). Os dados obtidos foram transformados e submetidos ao ANOVA e teste de Tukey e em seguida analisados por meio do SAS, com significância fixada em 5%. Resultados: isolada ou em associação com as diferentes concentrações de F, a CHX demonstrou maior potencial em reduzir os níveis de SM quando comparada ao uso isolado de F em ambas concentrações ou com o controle negativo (p < 0,05). Conclusão: o uso da combinação de F e CHX não apresentou efeito adicional na redução dos níveis de SM quando comparado ao uso isolado de CHX.